Santos – Buy Signal

Posted on | by Leon Hinde

Santos has revised the offer for the merger under which Oil Search investors would receive 0.6275 new Santos shares for each Oil Search share held, implying $4.29 per Oil Search share based on July 19 prices.

The combined entity would become an ASX top-20 company, overtaking Woodside Petroleum as the nation’s largest oil and gas producer.

Northern Star – Buy

Posted on | by Leon Hinde

Northern Star Resources is under Algo Engine buy conditions and is our preferred gold exposure.

NST continues to deliver strong results in the June quarter. Group production finished with 450koz at $1460oz, (up 23%), whilst seeing costs come down almost 10%.

We continue to see the twin factors of a strong gold price and cost-saving, (post-merger with SAR), helping to support the share price.

FMG – Algo Buy Signal

Posted on | by Leon Hinde

Fortescue Metals Group has been in our ASX model portfolios since July 2019 with multiple buy signals. We are again presented with another reminder of the opportunity to accumulate FMG.

FMG is set to report its FY21 result on 30 August. An increase in shipments volumes and higher realised prices in FY21 will drive a strong financial result.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.